Kimberly Westrich Addresses Patient-Centricity Strategies, Benefits in Health Care
April 18th 2024Kimberly Westrich, MA, of the National Pharmaceutical Council, addresses the benefits of incorporating patient-centricity throughout the health care system to foster more accurate and better quality of care.
Watch
Dr Julie Patterson Discusses Potential Unintended Effects of the IRA on Drug Development
April 3rd 2024Julie Patterson, PharmD, PhD, senior director of research at the National Pharmaceutical Council, discussed potential impact of the Inflation Reduction Act of 2022 (IRA) on small molecule drug research and development investments toward subsequent indications.
Watch
Dr Sharon Phares Lists the Many Factors Physicians Should Consider When Choosing Therapies
May 18th 2022Sharon Phares, PhD, MPH, chief scientific officer of the National Pharmaceutical Council, explained the importance of taking multiple factors into consideration when making health care decisions.
Watch
Dr Sharon Phares Speaks on How Value Assessments Can Improve Care Imbalances for Women
May 13th 2022Marking Women's Health Month, Sharon Phares, PhD, MPH, chief scientific officer of the National Pharmaceutical Council, detailed how value assessments can address health care imbalances for women.
Watch
The Myth of Average: Why Individual Patient Differences Matter
January 19th 2022In the newly-updated booklet, The Myth of Average: Why Individual Patient Differences Matter, the National Pharmaceutical Council (NPC) explores the barriers patients face when navigating the health care system and identifies opportunities for health care decision-makers to build better health care benefits and improve patient access to needed treatments.
Read More
National Pharmaceutical Council Appoints Dr. Sharon Phares as Chief Scientific Officer
January 18th 2022The National Pharmaceutical Council (NPC), a health policy research organization dedicated to the advancement of good evidence, science and medical innovation, announced the appointment of Sharon Phares, PhD, MPH, as chief scientific officer.
Read More
Kimberly Westrich on Incentivizing Value-Based Care in Benefit Design and Reimbursement Strategies
November 28th 2021Kimberly Westrich, MA, vice president of health services research at the National Pharmaceutical Council, discusses the shift to a value-based system from a fee-for-service one and how the health care system can incentivize high-value care.
Watch
Redefining Value Assessment to Better Engage Employers, Optimize Health Care Decision-Making
June 3rd 2021Stakeholders discuss barriers and solutions to employer engagement on value assessment, which includes redefining goals to that of the employer and patient, and moving beyond the scope of cost and clinical outcomes.
Read More
Dr Matthew Reynolds Addresses Pre-, Postpandemic Implications for Real-world Data and Research
May 20th 2021Matthew Reynolds, PhD, vice president of real-world evidence at IQVIA, discusses findings of a recent paper with the National Pharmaceutical Council on how COVID-19 affected real-world data and research, as well as implications for future studies.
Watch
How Shared Decision-Making, Patient Decision Aids Impact Cost, Utilization
May 14th 2021Panelists of a session at the Pharmacy Quality Alliance 2021 Annual Meeting explore how shared decision-making and patient decision aids can promote appropriate care and treatment adherence, as well as lower cost and utilization of health care services.
Read More
Bang for the Buck: How Health Care Innovation Affects Life Expectancy and Patient Well-Being
November 11th 2020During a webinar, experts discussed where health care has improved life expectancy and the relationship between cost and relative contribution that each area makes to life improvement and expectancy.
Read More
Dr Robert Dubois Details the Vital Importance of Increasing Healthcare Spending Discussions
November 1st 2019Discussions around healthcare spending have been ignored for decades, but Robert Dubois, MD, PhD, chief science officer and executive vice president at National Pharmaceutical Council, believes we have the ability to start those discussions now.
Watch
Panelists Debate the Role of ICER: Useful Overseer of Prices, or Oppressor of Choice?
May 22nd 2019Representatives from different parts of the healthcare system, as well as an outside observer, weighed in on whether the reports issued by the Institute for Clinical and Economic Review (ICER) are taking away patient choice.
Read More
In Developing Payment Mechanisms for Gene Therapies, the US Has a Long Road Ahead
November 21st 2018Even if gene therapies do prove to be cost-effective in providing patients with much-needed treatments for genetic diseases, the question of how to pay for these therapies remains largely unanswered.
Read More
Engaging Employees in Health Benefit Design Increases Satisfaction With Coverage Options
November 21st 2018During a case study, employees were more willing to have less robust coverage in areas like dental, vision, and diagnostic benefits so that the group could have access to more comprehensive mental health and maternity services.
Read More